Ipca Labs.

IPCALABORATORIES21 Feb 2024
Pharmaceuticals
-15.05 (-1.22%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Ipca Labs.
Ipca Labs.
Pharmaceuticals
IPCALABORATORIES21 Feb 2024
-15.05 (-1.22%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Ipca Labs. - Share Price & Details

Lowest Today
1213.3
Highest Today
1246.85
Today’s Open
1240
Prev. Close
1235.4
52 Week High
1263.95
52 Week Low
669.8
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
49.99%
Upper Circuit
Lower Circuit
P/E TTM
56.14
P/B Ratio
4.98
Traded Value(Cr)
0.46
EPS TTM
21.7
Book value
Dividend
0.33%

Price Performance

5.69 %
1 Wk
12.79 %
1 M
13.53 %
3 M
49.99 %
1 Y
9.02 %
YTD

Traded Volume Movement

Technical Details

Support 3
1174
Support 2
1194
Support 1
1207
Pivot Point :
1227
Resistance 1
1241
Resistance 2
1261
Resistance 3
1274

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ipca Laboratories Ltd
₹1,220.35(-15.05/-1.22%)
1,220.35-15.0530,960.7949.9956.144.98
Lupin Ltd
₹1,599.35(+12.30/0.78%)
1,599.35+12.3072,848.63138.5535.353.78
J B Chemicals & Pharmaceuticals Ltd
₹1,673.25(+24.30/1.47%)
1,673.25+24.3025,960.7070.9451.289.67
Sanofi India Ltd
₹9,197.45(+71.00/0.78%)
9,197.45+71.0021,181.7370.4536.8829.24
IOL Chemicals & Pharmaceuticals Ltd
₹417.75(-10.75/-2.51%)
417.75-10.752,452.4235.4814.221.54
Brooks Laboratories Ltd
₹128.50(-1.65/-1.27%)
128.50-1.65337.2734.920.004.91

About Ipca Laboratories Ltd

Ipca Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 30906.25 crores. It has reported a sales of Rs. 1506.83 crores and a net profit of Rs. 136.94 crores for the quarter ended December 2018. The company management includes Premchand Godha, Premchand Godha,A K Jain,Pranay Godha,Prashant Godha,Anand T Kusre,Manisha Premnath,Kamal Kishore Seth,Narendra Mairpady,Harish P Kamath (Ipca Laboratories Ltd) among others.
Chairman
Premchand Godha
Registered office
48 Kandivli Industrial Estate,Kandivli (West),Mumbai,Maharashtra,400067
FAX :91-22-28686613
Background
Incorporation Year1949
Face Value₹1
Market Lot1

Latest News

Top Gainers and Losers today on 21 February, 2024: Tata Steel, SBI!
The Nifty closed at 22196.95, down by 0.64% for the day. Throughout the day, the Nifty reached a high of 22249.4 and a low of 21997.95. On the other hand, the Sensex traded within the range of 73267.8 and 72450.56, closing 0.59% lower at 73057.4, which was 434.31 points below the opening price. The Nifty Midcap 50 underperformed the Nifty 50, closing 1.22% lower.
21 Feb 2024 | 05:38 PM
Technical View: Nifty forms Engulfing Bear candle post record high!
The Nifty50 index continued to touch record highs but failed to build on early gains and came under pressure on February 21 after posting positive returns in last six days. After hitting new high of 22,249.40 in early session, the Nifty index witnessed rangebound movement in the first half. However, profit booking led by majority of sectors in the second half dragged the Nifty.
21 Feb 2024 | 05:31 PM
📢 Sensex declines 434 points at the close; Nifty ends above 22,000
📈 Domestic benchmark indices closed on a negative note today.
📢 At 3:30 PM, the Sensex tanked by 434.31 points or 0.59% at 72,623.09, and the Nifty was down 141.90 points or 0.64% at 22,055.05.
📊Among sectoral, Nifty PSU Bank (⬆️0.60%) turned out to be the best performer while Nifty Energy (⬇️ 1.68%) saw considerable selling.
21 Feb 2024 | 03:44 PM
Most Nifty Midcap 100, Smallcap 100 companies record sluggish Q3 earning...
The earnings growth for Nifty Midcap 100 and Nifty Smallcap 100 companies has not seen a sustained recovery in the December quarter. Operating profit growth has slowed due to low sales and demand. Nifty Largecap 100 showed strong profit growth, while mid and small caps underperformed the benchmark index. Analysts caution against investing in mid and small caps due to high valuations.
21 Feb 2024 | 01:05 PM
Mid-day Mood | Nifty, Sensex trade flat as IT, Media stocks drag!
On February 21, the benchmark Sensex and Nifty indices saw a flat trading session with the Nifty reaching an all-time high in the morning before facing a dip due to corrections in media and IT stocks. However, the market was supported by gains in metal stocks and a record-high BSE market cap of $4.7 trillion, indicating strength. Analysts expect a pre-election rally and are awaiting US FOMC.
21 Feb 2024 | 12:28 PM

Is Ipca Labs a government-run institution?

No, IPCA Laboratories is not a government-run organization. It is a privately-owned pharmaceutical company based in India. IPCA Laboratories was founded in 1949 and has since grown to become one of the leading pharmaceutical companies in India.

Who is Ipca Labs’ owner?

IPCA Laboratories is a publicly-traded company and its ownership is spread among its shareholders. The Promoter of IPCA Labs is Mr. Premchand Godha and his family.

How well is Ipca Labs doing?

IPCA Laboratories operates in the pharmaceutical industry and has a diverse product portfolio that includes medicines for various therapeutic segments, including antimalarials, anti-bacterial, pain management, and cardiovascular drugs. Ipca Labs’ consolidated revenue has gone from Rs. 3773.18 crores in March 2019 to  Rs. 5,829.79 crores on 31 March 2022. The net profit has gone from Rs. 443.03 crores to Rs. 910.95 crores in the same period. Ipca Labs stock has given a positive return of 10.05% over the past three years and a negative return of -18.57% over the past one year.

What are the latest results of Ipca Labs?

The last fiscal result of Ipca Labs was declared in March 2022 and they reported a consolidated revenue of INR 5,829.79 crore and net profit of Rs. 910.95 crores.

What are the potential catalysts that positively impact the stock price of Ipca lab?

Some potential catalysts that may positively affect IPCA Laboratories' stock price could include: Strong financial results Expansion in new markets Launch of new products Regulatory approvals Industry trends
Click here to see your activities